The determinants of court selection in patent litigation -- The effects of bifurcation in patent litigation systems … -- The timing of patent transfers in Europe. …Applying novel datasets, Fabian Gäßler analyzes how key aspects of the current patent system in Europe and Germany …

, Eric C. Matolo -- Chapter 5. SSPPU: FRAND as Trust by Nicolas Petit -- Chapter 6. FRAND Commitments in Patent Portfolio … standard essential patent (SEP) holders. It also discusses the role of standards setting organizations / standards developing …

The European Patent System is facing major challenges resulting from an extension of patentable subject matter leading … to an increasing number of patent applications. The European Patent Office has responded with admirable flexibility, but … opposition figures and changing behaviour of patent applicants. Stefan M. Wagner analyses problems associated with institutional …

Spannungsfeld zwischen Rechtsprechung und Unternehmensbewertung -- Grundlagen des Zivilprozessrechts und der … funktionalen Unternehmensbewertung -- Schadensermittlung nach der Rechtsprechung und aus funktionaler Sicht -- Adaption der … Hauptfunktionen der Bewertung auf den Zivilprozess. …

common in recent years, such incentives – ranging from patent fee subsidies and patent box tax deductions to inventor …

the patent maintenance time granted by the United States, Germany, France, Japan and South Korea. Such issues include the … capability of technological innovation based on the patent maintenance time; the patent maintenance times in different … technologies in the energy-saving industry, the patent protection of Traditional Chinese Medicine, the impact on the R&D industry …

This book proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and … development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent …-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical …